nedocromil sodium , when inhaled by patients with asthma ( 0.05-0.50 % nebulized , 0.5-4.0 mg m.d.i . ) , has been shown to inhibit immediate bronchoconstriction provoked by challenges with allergen ( 10 studies ) , exercise ( five studies ) , isocapnic hyperventilation , fog and sulphur dioxide ( one study each ) and adenosine ( two studies ) .
C0886658
nedocromil sodium
C0004096
asthma